Skip to content

Released Apr 26, 2018, before the open

10-Q filed Apr 26, 2018, 26 days after period end · 0000917520-18-000019

Q1 2018 · 10-Q
Revenue$357.08M+38.1% vs Q1 2017−3.1% vs Q4 2017
Net Income$10.99M+71.9% vs Q1 2017−75.2% vs Q4 2017
EPS Diluted$0.14+75.0% vs Q1 2017−75.0% vs Q4 2017
Gross Profit$212,860,000+23.7%
Operating Income$25,579,000+156.8%
Operating Cash Flow$41,531,000+43.8%
Free Cash Flowderived$26,144,000+32.8%
Margins · derived
Gross margin59.6%−6.9 pt vs Q1 2017
Operating margin7.2%+3.3 pt vs Q1 2017
Net margin3.1%+0.6 pt vs Q1 2017

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ1 2018Q1 2017Q1 2016Q1 2015
Revenue$357.08M$258.64M$236.77M$202.53M
Net Income$10.99M$6.39M$13.42M$8.38M
EPS Diluted$0.14$0.08$0.18$0.13

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR